Adaptive Biotechnologies Corp (ADPT)
Cost of Revenue
$20.59M
Quarterly · Period ending: · USD
ADPT Cost of Revenue
Latest reported$20.59Mperiod ending
Latest reported$20.59Mperiod ending
ADPT Quarterly Cost of Revenue ($3.99M → $20.59M)
Quarterly cost of revenue
High-resolution chart · PNG
ADPT cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 20,588,000 | |
| 18,708,000 | |
| 18,224,000 | |
| 18,157,000 | |
| 17,999,000 | |
| 16,979,000 | |
| 18,045,000 | |
| 16,667,000 | |
| 19,317,000 | |
| 18,051,000 | |
| 19,616,000 | |
| 19,346,000 | |
| 17,910,000 | |
| 18,681,000 | |
| 16,589,000 | |
| 14,907,000 | |
| 13,221,000 | |
| 13,192,000 | |
| 14,356,000 | |
| 14,189,000 | |
| 10,765,000 | |
| 9,991,000 | |
| 6,222,000 | |
| 6,053,000 | |
| 4,912,000 | |
| 5,343,000 | |
| 5,951,000 | |
| 5,601,000 | |
| 5,734,000 | |
| 4,988,000 | |
| 5,275,000 | |
| 5,360,000 | |
| 5,044,000 | |
| 3,989,000 |